Neuroderm, Ltd.
USPTO PatentsView assignee record - 48 granted patents across 6 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61K (Preparations FOR Medical, Dental OR Toiletry Purposes).
The verdict
According to USPTO PatentsView, Neuroderm ranks #6,929 of 49,997 tracked US assignees by granted-patent volume, with 48 patents across 6 technology areas.
- #6,929
- of 49,997 US assignees by volume
- Top 45%
- by Innovation Score (37.1/100)
- 10.1
- avg claims per patent
- +88%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R6929 · Foreign Corporation #6,929 · 48 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 48 grants
- UPPER-Q #6,929/49,997
- PHOTO-FINISH Neapco Intellectual…
- CPC-NARROW A61K · 6 areas
- INNOV-THIN 37.1/100
- CLAIMS-PAR 10.1 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +88% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Neapco Intellectual Property Holdings, LLC (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Neuroderm’s 37.1 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Neuroderm
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Actega DS · near
Actega DS · near
37 score
- Neuroderm · this assignee
Neuroderm · this assignee
37 score
- ReCarbon · near
ReCarbon · near
37 score
- Tripwire · near
Tripwire · near
37 score
- Tusker Medical · near
Tusker Medical · near
37 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Neuroderm's Innovation Score is 37.1/100 (top 45% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Neuroderm?
Each dot is one of Neuroderm’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neuroderm’s own 10.1 claims/patent is at or below the 17.8 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Neuroderm's grants concentrate
Neuroderm, Ltd. is a focused PatentsView assignee: 6 CPC subclasses with 41.7% of grants classified under A61K (Preparations FOR Medical, Dental OR Toiletry Purposes). Peak complete grant year is 2022 (10 grants) versus a trough of 3 in 2016. By volume, Neuroderm sits between Novozymes Bioag A/S and Perftech, Inc..
Neuroderm's three-year grant acceleration
Neuroderm, Ltd. shows 20 grants in 2022–2024 against only 15 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Neuroderm's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Novozymes Bioag A…
Novozymes Bioag A/S
48 patents
- Neapco Intellectu…
Neapco Intellectual Property Holdings, LLC
48 patents
- Netsia
Netsia, Inc.
48 patents
- Netsuite
Netsuite Inc.
48 patents
- Nextvr
NextVR Inc.
48 patents
- Okinawa Institute…
Okinawa Institute OF Science AND Technology School Corporation
48 patents
- Openet Telecom
Openet Telecom Ltd.
48 patents
- Perftech
Perftech, Inc.
48 patents
- Neuroderm ◀
Neuroderm, Ltd.
48 patents
What this shows Neuroderm holds 48 patents at rank #6,932, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Neuroderm
By rank, the assignees closest to #6,932 in granted patent volume.
- Novozymes Bioag A/S #6,928 · 48 patents
- Neapco Intellectual Property Holdings, LLC #6,929 · 48 patents
- Netsia, Inc. #6,930 · 48 patents
- Netsuite Inc. #6,931 · 48 patents
- NextVR Inc. #6,933 · 48 patents
- Okinawa Institute OF Science AND Technology School Corporation #6,934 · 48 patents
- Openet Telecom Ltd. #6,935 · 48 patents
- Perftech, Inc. #6,936 · 48 patents
Leaders in A61K (Preparations FOR Medical)
Other assignees with the most granted patents in Neuroderm's primary technology class.
- The Regents of the University of California 1,779 in class
- L'Oreal 1,250 in class
- Novartis AG 988 in class
- The Procter & Gamble Company 985 in class
- The Board of Regents of the University of Texas System 950 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 813 in class
- The Trustees of the University of Pennsylvania 768 in class
- Merck Sharp & Dohme LLC 760 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Neuroderm, neither rank-band nor same-CPC leaders (those blocks stay above). In A61K (Preparations FOR Medical), Neuroderm ranks #1,122 of 7,163 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (37 here).
Neuroderm's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
37 Top 45% higher than 55% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2015 | 5 | 10.4% |
| 2016 | 3 | 6.3% |
| 2018 | 3 | 6.3% |
| 2019 | 5 | 10.4% |
| 2020 | 5 | 10.4% |
| 2021 | 5 | 10.4% |
| 2022 | 10 | 20.8% |
| 2023 | 4 | 8.3% |
| 2024 | 6 | 12.5% |
| 2025partial year | 2 | 4.2% |
Which technologies does Neuroderm, Ltd. patent most?
Top 6 of 6 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Neuroderm, Ltd.'s patent record in context - here's where to go next.
- Neuroderm, Ltd.'s lead technology class is A61K (Preparations FOR Medical, Dental OR Toiletry Purposes), 41.7% of its portfolio - see every assignee active in that class. Explore A61K
- Ranked #6,929 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Neuroderm, Ltd. against Novozymes Bioag A/S, an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 37.1/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.